Zogenix Puts Focus On Safety In Seizure Patients
Zogenix Puts Focus On Safety In Seizure Patients By Ed Miseta, Chief Editor, Clinical Leader Follow Me On Twitter @EdClinical Zogenix has been part of the drug development industry for about 12 years. The public company, located just across the Bay Bridge from San Francisco, has now been through a couple of iterations. It started out as a pain treatment company but quickly realized that was not an area where it could make a transformational difference in patients lives. In 2015, after a few yea...
Source: clinicalleader.com